DEA Warns of Sharp Increase in Counterfeit Prescription Pills
/By Pat Anson, PNN Editor
The U.S. Drug Enforcement Administration has issued a public safety alert warning of a sharp increase in the black market of fake painkillers and other counterfeit medications containing illicit fentanyl and methamphetamine. The alert, the DEA’s first in six years, coincides with the launch of a public awareness campaign to educate the public about the dangers of counterfeit pills.
“The United States is facing an unprecedented crisis of overdose deaths fueled by illegally manufactured fentanyl and methamphetamine,” DEA Administrator Anne Milgram said in a statement. “Counterfeit pills that contain these dangerous and extremely addictive drugs are more lethal and more accessible than ever before. In fact, DEA lab analyses reveal that two out of every five fake pills with fentanyl contain a potentially lethal dose.
It takes only two milligrams of fentanyl – an amount small enough to fit on the tip of a pencil – to constitute a lethal dose. The DEA says it has seized over 9.5 million fake pills so far this year, which is more than the last two years combined.
A recent raid on a home in Perris, California resulted in the seizure of 46 pounds of carafentanil, – a chemical cousin of fentanyl – which is potentially enough to kill more than 50 million people, according to the Riverside County District Attorney.
Carfentanil is a synthethic opioid 100 times more potent than fentanyl and 10,000 times more potent than morphine.
FAKE OXYCODONE PILLS
The DEA says most of the counterfeit pills manufactured or smuggled into the U.S are produced by Mexican drug cartels, using illicit chemicals that originate in China.
One of the most commonly produced fake pills are tablets made to look like 30mg oxycodone pills. Known on the street as “Mexican Oxy” or “M30s,” the tablets are virtually indistinguishable from legitimate oxycodone pills used for pain relief.
Law enforcement agencies are also finding counterfeit anti-anxiety medications made to look like Xanax and fake pills that look like the stimulant Adderall, which are made with methamphetamine.
‘One Pill Can Kill’
The goal of the DEA’s “One Pill Can Kill” campaign is to make the public more aware of the proliferation of counterfeit medications — now found in every state — and to warn drug users not trust any pill that doesn’t come from a pharmacist.
“Counterfeit pills have become a real and viable threat to the American People,” said Daniel Comeaux, Special Agent in Charge of the DEA’s Houston Division. “We caution every person to never consume any pill that is not sourced from a licensed pharmacy. These illicit counterfeit pills often contain fentanyl, where just a miniscule amount can result in death.”
Ironically, the DEA itself has played a significant role in the profusion of fake pills and its PR campaign is little more than a fig leaf covering years of disastrous policies.
Counterfeit medication made with illicit fentanyl first began appearing in quantity in the U.S. in 2016, around the same time federal and state regulators began recommending more cautious opioid prescribing for pain.
Faced with pressure from Congress to combat the so-called opioid epidemic by cracking down on painkillers, the DEA began cutting the legal supply of opioids in 2017. It has reduced opioid production quotas for five consecutive years, cutting the legal supply of hydrocodone and oxycodone in half.
The agency also began arresting and prosecuting doctors and pharmacists thought to be prescribing or dispensing opioids excessively, and revoked the DEA registrations of hundreds of physicians. As a result, opioid prescribing fell to 20-year lows, but the crackdown has had a negligible impact on drug overdoses, which rose to record levels.
With opioid medication harder to obtain, illegal online pharmacies began to proliferate and legitimate patients turned to street drugs for relief. A recent PNN survey of pain patients found that nearly 10% have obtained prescription opioids from family, friends or the black market.
In a 2020 report, the DEA said drug cartels were actively targeting pain sufferers as potential customers for counterfeit medication. The report said nearly two-thirds (64%) of people who misuse painkillers “identified relieving pain as the main purpose” of their drug use.
